Cartesian Therapeutics In... (RNAC)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

18.68

0.08%

After-hours Dec 13, 2024, 04:00 PM EST

Cartesian Therapeutics Inc. Forcast

Stock Price Forecast

The 7 analysts with 12-month price forecasts for RNAC stock have an median target of 41, with a low estimate of 39 and a high estimate of 45. The median target predicts an increase of 119.60% from the current stock price of 18.67.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$39	$41.6	$41	$45
Change	108.89%	122.82%	119.60%	141.03%

AI Analyst Report

HC Wainwright & Co. has reaffirmed a Buy rating on... Unlock content with Pro Subscription

Updated Dec 04, 2024

Rating	Jul 24	Aug 24	Sep 24	Oct 24	Nov 24	Dec 24
Strong Buy	1	0	0	0	0	1
Buy	3	3	2	1	3	1
Hold	1	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	3	2	1	3	2

Financial Forecast this Year

Revenue This Year

41.44M

from 26.00M

59.3%

from 26.00M

Revenue Next Year

7.33M

from 41.44M

-82.3%

from 41.44M

EPS This Year

-4.76

from -42.58

88.8%

from -42.58

EPS Next Year

-3.79

from -4.76

20.4%

from -4.76